STAT+: Overseas grants could be \u2018closed down\u2019 by NIH under new policy, internal email suggests
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
A National Institutes of Health policy change on funding of foreign scientists is far more sweeping than described in a Thursday announcement, according to an internal email that indicates international clinical trials and other research will be strictly vetted going forward.<\/p>\n
The agency said Thursday that it will not renew or issue new \u201cforeign subawards\u201d<\/a> \u2014 NIH funds that a U.S. researcher can give to a collaborator in another country to help complete a project \u2014 as the agency seeks to overhaul its $47 billion biomedical research portfolio. In a statement<\/a>, NIH director Jay Bhattacharya said that this freeze on foreign subawards, while the agency establishes a new system for awarding grants to international collaborators over the next six months, is intended to address national security concerns and a lack of transparency in how NIH dollars are spent.<\/p>\n But privately, NIH leadership is making it clear that the moves are part of a broader America First agenda that seeks to dramatically reduce U.S. participation in international science.\u00a0<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n